Leap Therapeutics, Inc. (LPTX) Financials

Stock symbol LPTX is outdated, potentially delisted? Maybe it is available on other exchange?

LPTX Assets vs Liabilities

Date	Assets	Liabilities
Dec. 31, 2023	72.8 million	12.7 million
Sept. 30, 2023	83.0 million	11.0 million
June 30, 2023	95.9 million	11.8 million
March 31, 2023	106.5 million	78.2 million

LPTX Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
Dec. 31, 2023	-10.4 million	1.3 million
Sept. 30, 2023	-10.5 million	1.3 million
June 30, 2023	-10.2 million	1.3 million
March 31, 2023	-12.7 million	1.3 million

LPTX Net Income

No data available :(

LPTX Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
Dec. 31, 2023	70.6 million	-	262000
Sept. 30, 2023	80.7 million	-	369000
June 30, 2023	91.4 million	-	474000
March 31, 2023	102.0 million	-	577000

LPTX Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
Dec. 31, 2023	27.0 million
Sept. 30, 2023	27.0 million
June 30, 2023	14.7 million
March 31, 2023	12.9 million

LPTX Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
Dec. 31, 2023	-	11.7 million	3.1 million	110000
Sept. 30, 2023	-	11.5 million	3.3 million	-
June 30, 2023	348000	11.1 million	3.6 million	-
March 31, 2023	348000	38.9 million	3.8 million	-

LPTX Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
Dec. 31, 2023	634000	110000
Sept. 30, 2023	-	107000
June 30, 2023	-	106000
March 31, 2023	-	104000

LPTX

Price: $0.77

52 week price:

0.22

3.58

Earnings Per Share: -1.58 USD

P/E Ratio: -0.33

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 72793

Ebitda: -6.8 million

Market Capitalization: 21.9 million

Links:

LPTX on Yahoo Finance